Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies

被引:0
|
作者
Cho, Sung-Yeon [1 ,2 ,3 ]
Lee, Dong-Gun [1 ,2 ,3 ]
Kim, Won-Bok [2 ]
Chun, Hye-Sun [2 ]
Park, Chulmin [2 ]
Myong, Jun-Pyo [4 ]
Park, Yeon-Joon [5 ]
Choi, Jae-Ki [1 ,2 ]
Lee, Hyo-Jin [1 ,2 ]
Kim, Si-Hyun [1 ,2 ]
Park, Sun Hee [1 ,2 ]
Choi, Su-Mi [1 ,2 ]
Choi, Jung-Hyun [1 ,2 ]
Yoo, Jin-Hong [1 ,2 ]
机构
[1] Catholic Univ Korea, Div Infect Dis, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Vaccine Bio Res Inst, Seoul, South Korea
[3] Catholic Hematol Hosp, Seoul, South Korea
[4] Catholic Univ Korea, Occupat & Environm Med, Coll Med, Seoul, South Korea
[5] Catholic Univ Korea, Dept Lab Med, Coll Med, Seoul, South Korea
关键词
Aspergillus; azoles; drug resistance mechanisms; environmental microbiology; hematologic diseases; IN-VITRO SUSCEPTIBILITY; AZOLE RESISTANCE; INVASIVE ASPERGILLOSIS; AMPHOTERICIN-B; FUMIGATUS; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; PROPHYLAXIS; FLUCONAZOLE;
D O I
10.1128/JCM.02023-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collected all consecutive cases and clinical isolates of culture-positive proven/probable invasive aspergillosis patients from January 2016 to April 2018 and sampled the air inside and outside the hospital. Cryptic species-level identification of Aspergillus, antifungal susceptibilities, and cyp51 gene sequencing were performed, and clinical data were analyzed. This study was conducted as part of the Catholic Hematology Hospital Fungi Epidemiology (CAFE) study. A total of 207 proven/probable invasive aspergillosis and 102 clinical and 129 environmental Aspergillus isolates were included in this analysis. The incidence of proven/probable invasive aspergillosis was 1.3 cases/1,000 patient-days during the study period. Cryptic Aspergillus species accounted for 33.8%, with no differences in proportions between the clinical and environmental isolates. Section Nigri presented a high proportion (70.5%) of cryptic species, mainly from A. tubingensis and A. awamori: the former being dominant in environmental samples, and the latter being more common in clinical isolates (P < 0.001). Of 91 A. fumigatus isolates, azole-resistant A. fumigatus was found in 5.3% of all A. fumigatus isolates. Three isolates presented the TR 34 /L98H mutation of the cyp51A gene. Patients with invasive aspergillosis caused by azole-resistant A. fumigatus showed 100% all-cause mortality at 100 days. This study demonstrates the significant portion of cryptic Aspergillus species and clinical implications of azole resistance and underscores the comparison between clinical and environmental isolates.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Genetypic characterization and antifungal susceptibility profile of clinical Aspergillus flavus section Flavi isolates in Kuwait
    Khan, Z. U.
    Al-Wathiqi, F.
    Ahmad, S.
    [J]. MYCOSES, 2012, 55 : 193 - 193
  • [22] Comparison of Virulence between Clinical and Environmental Isolates of Aspergillus fumigatus
    A. Aufauvre-Brown
    J. S. Brown
    D. W. Holden
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 : 778 - 780
  • [23] Comparison of virulence between clinical and environmental isolates of Aspergillus fumigatus
    Aufauvre-Brown, A
    Brown, JS
    Holden, DW
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (11) : 778 - 780
  • [24] Antifungal susceptibility of clinical isolates of 25 genetically confirmed Aspergillus species collected from Taiwan and Mainland China
    Li, Ying
    Wang, He
    Zhao, Yu-Pei
    Xu, Ying-Chun
    Hsueh, Po-Ren
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (01) : 125 - 132
  • [25] Antifungal susceptibility of clinical isolates of 23 genetically confirmed Aspergillus species collected from Taiwan and Mainland China
    Li, Ying
    Wang, He
    Xu, Ying-Chun
    Hsueh, Po-Ren
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S31 - S32
  • [26] Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
    Wu, Ping-Feng
    Liu, Wei-Lun
    Hsieh, Min-Han
    Hii, Ing-Moi
    Lee, Yu-Lin
    Lin, Yi-Tsung
    Ho, Mao-Wang
    Liu, Chun-Eng
    Chen, Yen-Hsu
    Wang, Fu-Der
    [J]. EMERGING MICROBES & INFECTIONS, 2017, 6
  • [27] Antifungal susceptibility of molecularly confirmed Aspergillus species from clinical samples
    Tzar, Mohd Nizam
    Mustakim, Sahlawati
    Yusoff, Hamidah
    Tap, Ratna Mohd
    [J]. MALAYSIAN JOURNAL OF PATHOLOGY, 2024, 46 (01) : 71 - 78
  • [28] Identification of Candida Species from Clinical Isolates and Their Antifungal Susceptibility Pattern
    Deepthi, K. N.
    Menon, Ardra R.
    Nair, K. Prithi
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (24): : 1813 - 1817
  • [29] Species distribution and antifungal susceptibility profiles of clinical and environmental Fusarium isolates from Mexico: A multicenter study
    Montoya, Alexandra M.
    Rodriguez-Grimaldo, Joan E.
    Lopez-Jacome, Luis Esau
    Bonifaz, Alexandro
    Enriquez-Dominguez, Erika
    Castanon-Olivares, Laura R.
    Charles-Nino, Claudia Lisette
    Rodriguez-Rodriguez, Armando
    de J. Trevino-Rangel, Rogelio
    Rojas, Olga C.
    Gonzalez, Gloria M.
    [J]. MYCOLOGIA, 2024, 116 (02) : 258 - 266
  • [30] Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings
    Iatta, Roberta
    Nuccio, Federica
    Immediato, Davide
    Mosca, Adriana
    De Carlo, Carmela
    Miragliotta, Giuseppe
    Parisi, Antonio
    Crescenzo, Giuseppe
    Otranto, Domenico
    Cafarchia, Claudia
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (09) : 2365 - 2372